Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 225

1.

[Association of plasmapheresis and high doses of intravenous immunoglobulins in the treatment of myasthenia gravis].

Tatay J, Díez-Tejedor E, Frank A, Tejada J, Marrero C, Barreiro P.

Rev Neurol. 1997 Sep;25(145):1402-6. Spanish.

PMID:
9377299
[PubMed - indexed for MEDLINE]
2.

High-dose intravenous immunoglobulin therapy for myasthenia gravis.

Jongen JL, van Doorn PA, van der Meché FG.

J Neurol. 1998 Jan;245(1):26-31.

PMID:
9457625
[PubMed - indexed for MEDLINE]
3.

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.

Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C.

Ann Neurol. 1997 Jun;41(6):789-96.

PMID:
9189040
[PubMed - indexed for MEDLINE]
4.

Myasthenia gravis: effect of immunoactive therapies.

Fornádi L, Horváth R, Bárdosi Z, Szobor A.

Acta Med Hung. 1994;50(1-2):83-92.

PMID:
7638045
[PubMed - indexed for MEDLINE]
5.

Sequential plasmapheresis and intravenous immunoglobulin therapy for refractory myasthenia gravis: case report.

Yeh JH, Chiu HC.

Ther Apher. 1999 Aug;3(3):271-4.

PMID:
10427628
[PubMed - indexed for MEDLINE]
6.

Treatment of myasthenia gravis with high-dose intravenous immunoglobulin.

Cosi V, Lombardi M, Piccolo G, Erbetta A.

Acta Neurol Scand. 1991 Aug;84(2):81-4.

PMID:
1950455
[PubMed - indexed for MEDLINE]
7.

The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis.

Hilkevich O, Drory VE, Chapman J, Korczyn AD.

Clin Neuropharmacol. 2001 May-Jun;24(3):173-6.

PMID:
11391130
[PubMed - indexed for MEDLINE]
8.

High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.

Takahashi H, Kawaguchi N, Nemoto Y, Hattori T.

J Neurol Sci. 2006 Sep 25;247(2):239-41. Epub 2006 Jul 28.

PMID:
16876198
[PubMed - indexed for MEDLINE]
9.

Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.

Pittayanon R, Treeprasertsuk S, Phanthumchinda K.

J Med Assoc Thai. 2009 Apr;92(4):478-82.

PMID:
19374297
[PubMed - indexed for MEDLINE]
10.

[Treatment of myasthenia gravis with intravenous immunoglobulin G (IVIG)].

Lavrnić DB, Stojanović V, Marinković Z, Pavlović S, Vidaković A, Apostolski S.

Srp Arh Celok Lek. 1995 May-Jun;123(5-6):146-8. Serbian.

PMID:
17974459
[PubMed - indexed for MEDLINE]
11.

High-dose intravenous immunoglobulin in myasthenia gravis.

Evoli A, Palmisani MT, Bartoccioni E, Padua L, Tonali P.

Ital J Neurol Sci. 1993 Apr;14(3):233-7.

PMID:
8314677
[PubMed - indexed for MEDLINE]
12.

Comparative analysis of therapeutic options used for myasthenia gravis.

Mandawat A, Kaminski HJ, Cutter G, Katirji B, Alshekhlee A.

Ann Neurol. 2010 Dec;68(6):797-805. doi: 10.1002/ana.22139.

PMID:
21061395
[PubMed - indexed for MEDLINE]
13.

Experience in the treatment of myasthenia gravis with double filtration plasmapheresis.

Chuang YC, Lee CT, Chen JB, Chee EC.

Chang Gung Med J. 2000 Feb;23(2):80-6.

PMID:
10835802
[PubMed - indexed for MEDLINE]
14.

Predictors of response to immunomodulation in patients with myasthenia gravis.

Katzberg HD, Barnett C, Bril V.

Muscle Nerve. 2012 May;45(5):648-52. doi: 10.1002/mus.23236.

PMID:
22499090
[PubMed - indexed for MEDLINE]
15.

The treatment of severe forms of myasthenia gravis.

Iani C, Caramia M, Morosetti M, Loberti M, Palmieri MG, Meloni C, Gallucci MT, Casciani CU, Bernardi G.

Funct Neurol. 1998 Jul-Sep;13(3):231-7.

PMID:
9800150
[PubMed - indexed for MEDLINE]
16.

Intravenous immunoglobulin monotherapy in long-term treatment of myasthenia gravis.

Wegner B, Ahmed I.

Clin Neurol Neurosurg. 2002 Dec;105(1):3-8.

PMID:
12445915
[PubMed - indexed for MEDLINE]
17.

Double filtration plasmapheresis in myasthenia gravis--analysis of clinical efficacy and prognostic parameters.

Yeh JH, Chiu HC.

Acta Neurol Scand. 1999 Nov;100(5):305-9.

PMID:
10536917
[PubMed - indexed for MEDLINE]
18.

Plasmapheresis in severe forms of myasthenia gravis.

Morosetti M, Meloni C, Iani C, Caramia M, Galderisi C, Palombo G, Gallucci MT, Bernardi G, Casciani CU.

Artif Organs. 1998 Feb;22(2):129-34.

PMID:
9491902
[PubMed - indexed for MEDLINE]
19.

[Intensive care in myasthenic and cholinergic crises].

Popova LM, Piradov MA.

Anesteziol Reanimatol. 1996 Mar-Apr;(2):13-5. Russian.

PMID:
8754165
[PubMed - indexed for MEDLINE]
20.

Immunoglobulin treatment in refractory Myasthenia gravis.

Achiron A, Barak Y, Miron S, Sarova-Pinhas I.

Muscle Nerve. 2000 Apr;23(4):551-5.

PMID:
10716766
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk